Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics

• Published in: Phytotherapy research Vol. 30; no. 8; pp. 1207 - 1218
• Main Authors: Dong, Xiaoxv, Fu, Jing, Yin, Xingbin, Cao, Sali, Li, Xuechun, Lin, Longfei, Ni, Jian
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01-08-2016; Wiley Subscription Services, Inc; John Wiley and Sons Inc
• Subjects: emodin; Emodin - pharmacokinetics; Emodin - pharmacology; Humans; mechanisms; Medicine, Chinese Traditional - methods; pharmacokinetics; pharmacology; Plant Extracts - pharmacokinetics; Plant Extracts - pharmacology; Polygonum cuspidatum; Polygonum multiflorum; Review; Reviews; Rheum; toxicology; toxicology; pharmacokinetics; mechanisms; pharmacology; emodin
• ISSN: 0951-418X; 1099-1573
• DOI: 10.1002/ptr.5631

Emodin is a natural anthraquinone derivative that occurs in many widely used Chinese medicinal herbs, such as Rheum palmatum, Polygonum cuspidatum and Polygonum multiflorum. Emodin has been used as a traditional Chinese medicine for over 2000 years and is still present in various herbal preparations. Emerging evidence indicates that emodin possesses a wide spectrum of pharmacological properties, including anticancer, hepatoprotective, antiinflammatory, antioxidant and antimicrobial activities. However, emodin could also lead to hepatotoxicity, kidney toxicity and reproductive toxicity, particularly in high doses and with long‐term use. Pharmacokinetic studies have demonstrated that emodin has poor oral bioavailability in rats because of its extensive glucuronidation. This review aims to comprehensively summarize the pharmacology, toxicity and pharmacokinetics of emodin reported to date with an emphasis on its biological properties and mechanisms of action. Copyright © 2016 John Wiley & Sons, Ltd.